Sensus Healthcare, Inc. (SRTS)
- Previous Close
6.55 - Open
6.53 - Bid 6.40 x 100
- Ask 6.47 x 100
- Day's Range
6.32 - 6.53 - 52 Week Range
1.79 - 7.18 - Volume
54,492 - Avg. Volume
174,485 - Market Cap (intraday)
105.463M - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
15.66 - EPS (TTM)
0.41 - Earnings Date Nov 7, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.67
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
sensushealthcare.comRecent News: SRTS
View MorePerformance Overview: SRTS
Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SRTS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SRTS
View MoreValuation Measures
Market Cap
105.22M
Enterprise Value
86.94M
Trailing P/E
15.66
Forward P/E
11.78
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.88
Price/Book (mrq)
1.99
Enterprise Value/Revenue
2.39
Enterprise Value/EBITDA
9.70
Financial Highlights
Profitability and Income Statement
Profit Margin
18.27%
Return on Assets (ttm)
9.70%
Return on Equity (ttm)
13.44%
Revenue (ttm)
36.37M
Net Income Avi to Common (ttm)
6.64M
Diluted EPS (ttm)
0.41
Balance Sheet and Cash Flow
Total Cash (mrq)
14.52M
Total Debt/Equity (mrq)
0.87%
Levered Free Cash Flow (ttm)
-2.92M
Research Analysis: SRTS
View MoreCompany Insights: SRTS
SRTS does not have Company Insights